Article
Preferential mammary carcinogenic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human c-Ha-ras proto-oncogene transgenic rats.
Cancer science - 1 May 2004
Naito Akihiro, Suzuki Akane, Ueda Shinobu, Nomoto Hiroshi, Toriyama-Baba Hiroyasu, Asamoto Makoto, Tsuda Hiroyuki
Abstract excerpt
In order to clarify the susceptibility of the Hras128 rat harboring copies of the human c-Ha-ras proto-oncogene to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Hras128 rats were intragastically treated with 100 mg/kg PhIP 8 times (females) or 80 mg/kg PhIP 10 times (males) over a 9-week period, then sacrificed at weeks 12 and 30. Multiple mammary tumors of adenocarcinoma type were induced in all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
